ATM Mutations in Cancer: Therapeutic Implications
- PMID: 27413114
- DOI: 10.1158/1535-7163.MCT-15-0945
ATM Mutations in Cancer: Therapeutic Implications
Abstract
Activation of checkpoint arrest and homologous DNA repair are necessary for maintenance of genomic integrity during DNA replication. Germ-line mutations of the ataxia telangiectasia mutated (ATM) gene result in the well-characterized ataxia telangiectasia syndrome, which manifests with an increased cancer predisposition, including a 20% to 30% lifetime risk of lymphoid, gastric, breast, central nervous system, skin, and other cancers. Somatic ATM mutations or deletions are commonly found in lymphoid malignancies, as well as a variety of solid tumors. Such mutations may result in chemotherapy resistance and adverse prognosis, but may also be exploited by existing or emerging targeted therapies that produce synthetic lethal states. Mol Cancer Ther; 15(8); 1781-91. ©2016 AACR.
©2016 American Association for Cancer Research.
Similar articles
-
Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase.Mol Pharm. 2021 Jul 5;18(7):2470-2481. doi: 10.1021/acs.molpharmaceut.1c00166. Epub 2021 Jun 14. Mol Pharm. 2021. PMID: 34125542 Review.
-
Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).Mol Genet Genomic Med. 2020 Oct;8(10):e1409. doi: 10.1002/mgg3.1409. Epub 2020 Aug 3. Mol Genet Genomic Med. 2020. PMID: 32748564 Free PMC article.
-
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.Breast Cancer Res. 2018 Apr 17;20(1):28. doi: 10.1186/s13058-018-0951-9. Breast Cancer Res. 2018. PMID: 29665859 Free PMC article.
-
Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives.Neuromolecular Med. 2013 Sep;15(3):447-57. doi: 10.1007/s12017-013-8231-4. Epub 2013 Apr 30. Neuromolecular Med. 2013. PMID: 23632773
-
Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.Clin Genet. 2016 Aug;90(2):105-17. doi: 10.1111/cge.12710. Epub 2016 Jan 20. Clin Genet. 2016. PMID: 26662178 Review.
Cited by
-
Genomic profiling of thymoma using a targeted high-throughput approach.Arch Med Sci. 2020 Jul 3;20(3):909-917. doi: 10.5114/aoms.2020.96537. eCollection 2024. Arch Med Sci. 2020. PMID: 39050176 Free PMC article.
-
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.Mod Pathol. 2020 Dec;33(12):2544-2563. doi: 10.1038/s41379-020-0629-6. Epub 2020 Jul 23. Mod Pathol. 2020. PMID: 32704031 Free PMC article. Review.
-
COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic Target.Cancers (Basel). 2021 Feb 16;13(4):830. doi: 10.3390/cancers13040830. Cancers (Basel). 2021. PMID: 33669398 Free PMC article.
-
Cervical malignant mixed mesonephric tumour: A case report with local recurrence after six-years and next-generation sequencing analysis with particular reference to the ataxia telangiectasia mutated gene.Exp Ther Med. 2021 Apr;21(4):394. doi: 10.3892/etm.2021.9825. Epub 2021 Feb 24. Exp Ther Med. 2021. PMID: 33680116 Free PMC article.
-
Atypical ATMs: Broadening the phenotypic spectrum of ATM-associated hereditary cancer.Front Oncol. 2023 Feb 14;13:1068110. doi: 10.3389/fonc.2023.1068110. eCollection 2023. Front Oncol. 2023. PMID: 36865800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
